随机对照试验
医学
癌症
物理疗法
临床试验
梅德林
研究设计
生活质量(医疗保健)
随机化
干预(咨询)
癌症登记处
心理学
作者
Xia Yang,Huo Yongxin,Yanru Wang,Yanru Wang,Mingpei Li,Ran Zhang,Ling Liu,Yu Chen,You Wang,You Wang
出处
期刊:Psycho-oncology
[Wiley]
日期:2026-01-01
卷期号:35 (1): e70386-e70386
被引量:1
摘要
ABSTRACT Aims Digital tools offer scalable support for cancer survivors' psychological well‐being, however, direct efficacy comparisons between artificial intelligence (AI)‐Enhanced and clinician‐guided digital interventions are scarce. This study evaluated an AI‐Enhanced expressive writing intervention against clinician‐guided digital support and usual care for cancer survivors. Methods In this randomized controlled trial, 120 cancer survivors (111 completers) were randomized (1:1:1) to AI‐Enhanced, clinician‐guided, or usual care groups for a 4‐week expressive writing intervention. Outcomes, including depression, anxiety, fear of progression (FoP), and resilience, were assessed at baseline, post‐intervention, and 1‐month follow‐up between September 2024 and April 2025. Data were analyzed using repeated‐measures ANOVAs and thematic analysis of semi‐structured interviews. Results Both AI and clinician‐guided interventions significantly reduced depression (AI: d = 0.92; Clinician: d = 0.98) and anxiety (AI: d = 0.59; Clinician: d = 0.66) versus usual care, with comparable efficacy. However, clinician‐guided support demonstrated greater efficacy in reducing FoP ( d = 0.62 vs. AI). Resilience improved over time across all groups, with no significant inter‐group differences. Qualitatively, AI offered reduced stigma and accessibility, while the clinician‐guided approach provided valued empathetic connection. Conclusion AI‐Enhanced expressive writing is a viable, scalable tool for reducing depression and anxiety in cancer survivors. Yet, the greater efficacy of clinician‐guided digital support for complex issues like FoP highlights the value of human‐mediated empathy. This advocates for hybrid models in psychological care that integrate AI's scalability with the relational depth of clinical expertise to enhance survivor well‐being. Trial Registration Chinese Clinical Trial Registry (ChiCTR2400089455)
科研通智能强力驱动
Strongly Powered by AbleSci AI